No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Data science and biostatistics firm Physiomics said on Monday that both total income and pre-tax losses would exceed market expectations for the financial year ended 30 June.
Based on its unaudited year-end accounts, Physiomics expects to finish the year with total income of £834,000 and pre-tax losses of £419,000, representing an increase of approximately 46% in income and a 31% reduction in losses, reflecting the "positive growth trajectory" of the business and effective cost management.
Physiomics said it had continued to build its pipeline, with the average total value of contract wins over FY24 and FY25 reaching a record high of over £1.0m per year, a 63% increase on the yearly average over the previous five years.
The AIM-listed group added that it was confident that further revenue growth could be achieved in FY26.
Chief executive Dr Peter Sargent said: "I am thrilled that the changes we've made here at Physiomics are starting to have a positive effect on the company's performance. Not only will we exceed expectations for FY25, but we've started FY26 with record levels of contracted revenue yet to be recognised and are generating significant momentum across our key growth initiatives."
As of 0845 BST, Physiomics shares were up 3.16% at 0.49p.
Reporting by Iain Gilbert at Sharecast.com
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.
